PATENT CLAIM ANALYSIS

Application Number: 15947279
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["546", "155000"]

Abstract:
A compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of multiple myeloma.

Claim (Index 10):
The method according to  claim 1 , comprising administering one or more further drugs in a combination therapy with tasquinimod.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 91.0
- Lexical Diversity: 1.04545
- Patent Class: 546.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15510728', '15525086', '12315779', '12759578', '11513959']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7527540297952733
- 35 USC 102 Novelty (BERT): 0.5392613411279781
- Combined Prediction Score: 0.7314047609285438
- Mean Citation Score: 263.486534
- Max Citation Score: 385.55878
- Similarity Product: 225.2150900924492

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test